Sbir topic 417 phase I firm fixed price delivery: 06/14/2022 period of performance: 09/15/2021 to 06/14/2022
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91021C00031
- Awardee
-
Neuralrad LLC UEI DCWKBA5KJVY1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $454,559
Award facts
- Opportunity
-
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Pre-Solicitation · PHS20211 · Posted Jul 9, 2020
- A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals Solicitation · Posted Jul 28, 2020
- Contract value 100% obligated
- $454,559.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53717, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $55,000 | |
| Original award | $399,559 |
About this award
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from September 15, 2021 to June 14, 2022, with a total completion date of December 14, 2022. The contract is set aside for small businesses with fewer than 500 employees.
Quick answers
Who was awarded contract 75N91021C00031?
75N91021C00031 was awarded to Neuralrad LLC by National Cancer Institute (National Institutes of Health) on September 15, 2021.
How much is contract 75N91021C00031 worth?
The government has obligated $454,559 on 75N91021C00031.
Was contract 75N91021C00031 competed?
The extent of competition for 75N91021C00031 was full and open competition after exclusion of sources. The government received 9 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award